NuVasive released its preliminary unaudited financial results this week for the full year of 2013 and anticipates earning $683 million in revenue. The expected revenue is up from the previously-issued guidance of $670 million in 2013 revenue. NuVasive anticipates $725 million in revenue for 2014.
The company will announce its complete financial results for the fourth quarter and the full year after the market closes on March 3.
More Articles on Devices:
44 Spine & Orthopedic Devices Receive FDA 510(k) Clearance in December
MicroPort Scientific's Acquisition Creates MicroPort Orthopedics Division
Mazor Robotics Pens Deal with Hospital GPO to Provide Renaissance System Access
NuVasive Releases Preliminary Financials, Expects $683M in 2013 Revenue
Spinal TechCopyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.